ITMCTR2000003010招募中1 期
A randomized controlled clinical trial study protocol of Liuwei Dihuang Pills in the adjuvant treatment of diabetic kidney disease
Hospital of Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 25 至 75(—)
- 性别
- All
入选标准
- •1. Patients were diagnosed Diabetic Kidney Disease meeting the criteria of the 2014 Consensus of Experts on Prevention and Treatment of DKD of Chinese Diabetes Society;
- •2. Patients aged between 25 and 75 years old;
- •3. eGFR>=30mL/min/1.73m2 without dialytic treatments;
- •4. For patients with hypertension, blood pressure<=140/90 mmHg; for the elderly, systolic blood pressure (SBP)<= 150mmHg;
- •5. Glycosylated hemoglobin (HbA1c) should be less than or equal to 7%; for patients with serious complications such as recurrent hypoglycemia, severe microvascular or macrovascular complications, or it is difficult to meet the standard requirements despite adequate treatment, then HbA1c should be less than or equal to 8%;
- •6. Patients with ability to read, understand and write research-related materials, and voluntarily comply with all test requirements;
- •7. Patients voluntarily participate in the study and written the informed consent form.
排除标准
- •1. Severe infection, anemia, electrolyte imbalance, or acute complications of DM in the previous 4 weeks;
- •2. Severe cardiac, cerebral, hepatic, or hemorrhagic diseases, including cerebral infarction, cerebral hemorrhage, transient ischemic attack, myocardial infarction, unstable angina, heart failure, and hepatic inadequacy with aspartate transaminase (AST) or alanine aminotransferase (ALT) levels more than 2 twice the normal upper limit;
- •3. Use of corticosteroids or immunosuppressants in the previous 3 months;
- •4. Oliguria, anuria, severe edema, massive pleural or peritoneal effusion;
- •5. Renal transplantation;
- •6. Mental disorders;
- •7. Pregnancy or lactation;
- •8. Allergy to the trial drugs;
- •9. Participation in other clinical studies;
- •10. Incomplete understanding of the study, refusal to participate.
研究者
相似试验
尚未招募
不适用
A randomized controlled clinical trial study protocol of Bujing Yishi tablet in the treatment of Children and Adolescents with Low-grade MyopiaMyopiaITMCTR2100004611Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
已完成
不适用
Communication management: a trial comparing two strategies for information communication to patientsISRCTN01508870Donostia University Hospital (Hospital Universitario Donostia) (Spain)30
尚未招募
2 期
To assess the clinical efficacy of Ayurvedic interventions in managing asymptomatic to mild cases of COVID-19CTRI/2020/08/027346Shri Dhanwantry ayurevdic college and hospital
尚未招募
1 期
A prospective randomized controlled clinical trial for QSHY granule in the treatment of hyperlipidemia of phlegm and blood stasis typeHyperlipidemiaITMCTR2000003430Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
招募中
不适用
A prospective randomized controlled clinical trial of Pingmu Decoction combined with acupuncture in the treatment of non-active thyroid-related ophthalmopathyThyroid associated ophthalmopathyITMCTR2100004405onghua Hospital, Shanghai University of Traditional Chinese Medicine
